oxy-Arachidonoyl Ethanolamide – 50 mg

Brand:
Cayman
CAS:
883296-70-6
Storage:
-20
UN-No:
Excepted Quantity - 1170 / 3

AEA acts as an endogenous mimic of Δ9-THC, the psychotropic component of marijuana.{1134} oxy-AEA is the O-alkyl-N-acyl oxyhomologue of AEA. oxy-AEA is selective for the peripheral cannabinoid (CB2) receptor with Ki values of 0.47 and 0.081 µM for hCB1 and hCB2, respectively.{14122} In comparison, AEA has a greater affinity for the central cannabinoid (CB1) receptor with Ki values of 0.07 and 0.18 µM for hCB1 and hCB2, respectively. oxy-AEA is the first known fatty acid amide with a reversed CB1/CB2 affinity ratio.  

 

Available on backorder

SKU: 10008642 - 50 mg Category:

Description

A selective CB2 receptor ligand with Ki values of 0.47 and 0.081 µM for human CB1 and CB2 receptors, respectively.


Formal name: N-(2-hydroxyethoxy)-5Z,8Z,11Z,14Z-eicosatetraenamide

Synonyms:  oxy-AEA|oxy-Anandamide

Molecular weight: 363.5

CAS: 883296-70-6

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Fatty Amides||Product Type|Biochemicals|Receptor Pharmacology||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids